UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.1B |
| 2 |
NVIDIA
NVDA
|
+$2.82B |
| 3 |
Microsoft
MSFT
|
+$2.29B |
| 4 |
Amazon
AMZN
|
+$1.67B |
| 5 |
UnitedHealth
UNH
|
+$1.31B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$1.42B |
| 2 |
Amphenol
APH
|
+$419M |
| 3 |
Iron Mountain
IRM
|
+$322M |
| 4 |
HDFC Bank
HDB
|
+$212M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.75% |
| 2 | Financials | 12.99% |
| 3 | Consumer Discretionary | 11.48% |
| 4 | Healthcare | 10.94% |
| 5 | Communication Services | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
Occidental Petroleum Corp Warrants
OXY.WS
$32B
| $301K | ﹤0.01% |
10,937
| – | – |
|
2577
Lufax Holding
LU
$1.38B
| $301K | ﹤0.01% |
125,808
-97,772
| -44% | -$270K |
|
|
TIXT
2578
DELISTED
TELUS International
TIXT
| $288K | ﹤0.01% |
73,530
-26,948
| -27% | -$102K |
|
2579
Oric Pharmaceuticals
ORIC
$1.2B
| $287K | ﹤0.01% |
35,579
+12,545
| +54% | +$115K |
|
2580
Harmony Gold Mining
HMY
$10.1B
| $282K | ﹤0.01% |
34,308
-17,637
| -34% | -$171K |
|
|
LAR
2581
Lithium Argentina AG
LAR
$972M
| $271K | ﹤0.01% |
103,410
| – | – |
|
|
NYAX
2582
Nayax
NYAX
$2.49B
| $264K | ﹤0.01% |
9,040
| – | – |
|
2583
Lexicon Pharmaceuticals
LXRX
$1.04B
| $261K | ﹤0.01% |
353,508
+233,121
| +194% | +$281K |
|
2584
Dr. Reddy's Laboratories
RDY
$9.85B
| $261K | ﹤0.01% |
16,511
-24,734
| -60% | -$372K |
|
2585
Centuri Holdings
CTRI
$2.71B
| $253K | ﹤0.01% |
13,086
| – | – |
|
2586
Annexon
ANNX
$863M
| $252K | ﹤0.01% |
+49,062
| New | +$302K |
|
2587
Brown-Forman Class A
BF.A
$13.4B
| $251K | ﹤0.01% |
6,669
+2,431
| +57% | +$105K |
|
2588
4D Molecular Therapeutics
FDMT
$526M
| $247K | ﹤0.01% |
44,324
+2,925
| +7% | +$23K |
|
2589
Savers
SVV
$1.59B
| $245K | ﹤0.01% |
23,939
| – | – |
|
2590
Ambev
ABEV
$48.2B
| $245K | ﹤0.01% |
132,600
-250,000
| -65% | -$553K |
|
2591
HBT Financial
HBT
$1.3B
| $241K | ﹤0.01% |
10,983
-5,289
| -33% | -$120K |
|
2592
Tango Therapeutics
TNGX
$4.49B
| $237K | ﹤0.01% |
76,551
+1,249
| +2% | +$5.8K |
|
2593
Similarweb
SMWB
$632M
| $225K | ﹤0.01% |
15,912
| – | – |
|
2594
Perspective Therapeutics
CATX
$341M
| $224K | ﹤0.01% |
70,150
+11,472
| +20% | +$93.7K |
|
2595
Aveanna Healthcare
AVAH
$2.11B
| $223K | ﹤0.01% |
+48,781
| New | +$250K |
|
2596
ArriVent BioPharma
AVBP
$1.43B
| $218K | ﹤0.01% |
+8,165
| New | +$234K |
|
|
CRGX
2597
DELISTED
CARGO Therapeutics
CRGX
| $214K | ﹤0.01% |
14,832
+3,570
| +32% | +$64.8K |
|
|
GPGI
2598
GPGI Inc
GPGI
$3.9B
| $177K | ﹤0.01% |
+13,933
| New | +$176K |
|
|
FLNA
2599
Filana Therapeutics
FLNA
$46.4M
| $177K | ﹤0.01% |
75,084
+14,190
| +23% | +$249K |
|
2600
Invesco S&P 500 Quality ETF
SPHQ
$19.5B
| $139K | ﹤0.01% |
+2,079
| New | +$141K |
|
Similar funds
UBS AM's Q4 2024 Portfolio in Review
As of Q4 2024, UBS AM held 2,799 positions worth $429B, up 10% from $389B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
UBS AM deployed $33.4B of net new capital in Q4 2024, opening 50 new positions and adding to 1,945 existing holdings. Its largest new stake was Xtrackers MSCI USA Climate Action Equity ETF: 1,587,581 shares worth $58.8M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 33% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Pinduoduo, an estimated $1.42B trimmed.
- UBS AM's largest Q4 2024 buy was Xtrackers MSCI USA Climate Action Equity ETF: 1,587,581 shares worth $58.8M.
- UBS AM added most to Apple in Q4 2024, an estimated $3.1B increase.
- UBS AM's biggest Q4 2024 reduction was Pinduoduo, cutting an estimated $1.42B.
- UBS AM fully exited iShares MSCI India ETF in Q4 2024, selling an estimated $176M.
- UBS AM's ten largest holdings make up 32% of its $429B portfolio in Q4 2024.
- UBS AM opened 50 new positions and closed 145 in Q4 2024.
- UBS AM's portfolio value rose 10% quarter-over-quarter to $429B.
Based on UBS AM's 13F filing for Q4 2024, filed 14 Feb 2025.